Objectives

After participating in this educational activity, attendees should be able to:
1| Explain the mechanism of action of PCSK9 inhibitors

2| Describe the role of PCSK9 inhibitors in current guidelines

3| Evaluate current literature on the use of oral PCSK9 inhibitors ​

4| Interpret trial findings in the context of real-world practice​

Presenter(s): 
Ashley Roding, PharmD
PGY-2 Ambulatory Care Pharmacy Resident
Baystate Medical Center
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Ashley Roding, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
09/21/2026 - 2:00pm to 3:00pm EDT
Location: 
Hybrid
United States
See map: Google Maps
Add to calendar: 
  • 1.00 ACPE Contact Hours
  • 1.00 ACPE Technician contact hours
Please login or register to take this course.